2007, Number 1
Next >>
Cir Gen 2007; 29 (1)
Gastrointestinal stromal tumors: vision of the present towards the future
Azcoitia MF
Language: Spanish
References: 9
Page: 7-9
PDF size: 38.67 Kb.
ABSTRACT
No abstract
REFERENCES
Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med 2005; 353: 701-711.
Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983; 7: 507-19.
Nowain A, Bhakta H, Pais S, Kanel G, Verma S. Gastrointestinal stromal tumors: Clinical profile, pathogenesis, treatment strategies and prognosis. J Gastroenterol Hepatol 2005; 20: 818-824.
Tran T, Davila JA, El-Serag HB. The Epidemiology of malignant gastrointestinal stromal tumors: An analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 2005; 100: 162-8.
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231: 51-8.
Went PT, Dirnhofer S, Bundi M, Mirlacher M, Schrami P, Mangialaio S, et al. Prevalence of KIT expression in human tumors. J Clin Oncol 2004; 22: 4514-22.
Demetri GD, von Mehren M, Blanke ChD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472-80.
Pauls K, Merkelbach-Bruse S, Thal D, Büttner R, Wardelmann E. PDGFRalpha- and c-kit mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features. Histopathology 2005; 46: 166-75.
Baselga J. Targeting tyrosine kinases in cancer: The second wave. Science 2006; 312: 1175-8.
Full text